Research Field: Medicine, Clinical cancer epidemiology
1 in 3 Australian’s get cancer during their lives. There are many emerging treatments for cancer however the response of specific patients can differ greatly, both in terms of benefit and side-effects. As a pharmacist and clinical epidemiologist, Dr Ashley Hopkins aims to unleash the potential of emerging big data and machine learning to empower patients and oncologists to better understanding the pros and cons of cancer treatments.
Dr Hopkins applies high-level data science skills and collaborates with key international partners enabling access to comprehensive data from both randomised controlled trials and routine care. He uses these to undertake research predicting who will and will not benefit from anti-cancer therapies.
Dr Hopkins communicates his work widely through media including print media such as the Advertiser, Herald Sun and >10 other national newspapers and radio including 103.7FM, 3AW, 4BC and 2GB. He has established a consumer advisory group for his lab that meets quarterly. He is also an avid cyclist and fundraiser who has contributed to several Cancer Council fundraising events.
Ashley completed his PhD in 2016 at the University of South Australia. He is now a Senior Research Fellow at Flinders University (College of Medicine and Public Health).